Cohen Klingenstein’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Hold
4,430
0.01% 198
2026
Q1
$524K Hold
4,430
0.02% 186
2025
Q4
$557K Hold
4,430
0.02% 183
2025
Q3
$648K Hold
4,430
0.02% 177
2025
Q2
$691K Hold
4,430
0.02% 173
2025
Q1
$729K Hold
4,430
0.03% 170
2024
Q4
$722K Hold
4,430
0.02% 170
2024
Q3
$866K Hold
4,430
0.03% 175
2024
Q2
$768K Hold
4,430
0.03% 175
2024
Q1
$750K Hold
4,430
0.03% 182
2023
Q4
$874K Hold
4,430
0.04% 174
2023
Q3
$771K Hold
4,430
0.03% 176
2023
Q2
$763K Hold
4,430
0.03% 179
2023
Q1
$737K Hold
4,430
0.03% 181
2022
Q4
$649K Hold
4,430
0.03% 180
2022
Q3
$657K Hold
4,430
0.03% 176
2022
Q2
$761K Hold
4,430
0.04% 174
2022
Q1
$835K Hold
4,430
0.03% 175
2021
Q4
$1.08M Hold
4,430
0.04% 165
2021
Q3
$860K Hold
4,430
0.04% 188
2021
Q2
$826K Hold
4,430
0.04% 189
2021
Q1
$698K Hold
4,430
0.03% 198
2020
Q4
$733K Hold
4,430
0.04% 187
2020
Q3
$733K Hold
4,430
0.04% 179
2020
Q2
$607K Hold
4,430
0.04% 183
2020
Q1
$521K Hold
4,430
0.04% 181
2019
Q4
$586K Hold
4,430
0.03% 193
2019
Q3
$552K Buy
+4,430
New +$535K 0.03% 196

Other funds holding ZTS

Cohen Klingenstein's ZTS Position: Q2 2026 in Review

Cohen Klingenstein held its Zoetis (ZTS) position steady in Q2 2026 at 4,430 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #198.

Cohen Klingenstein first reported a position in ZTS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.08M in Q4 2021. 553 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Cohen Klingenstein held 4,430 shares of Zoetis worth $318K as of Q2 2026.
  • Cohen Klingenstein left its Zoetis share count unchanged in Q2 2026.
  • Zoetis made up 0.01% of Cohen Klingenstein's portfolio in Q2 2026, its #198 holding.
  • Cohen Klingenstein first reported a position in Zoetis in Q3 2019 and has held it in 28 quarters since.
  • Cohen Klingenstein's Zoetis position peaked at $1.08M in Q4 2021.
  • 553 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.